Answers are grounded in this paper and cite their sources.
The health benefits of probiotics depend on delivering viable cells to the intestine at therapeutically effective levels; however, many conventional hydrocolloid encapsulation systems fail to provide adequate protection against gastric acidity and bile stress, leading to substantial viability loss before intestinal release. Developing structurally reinforced yet biocompatible delivery systems therefore remains a critical challenge in functional food design. In this study, we engineered a strengthened alginate–pectin microencapsulation platform incorporating biosynthesized titanium dioxide nanoparticles (TiO₂ NPs) derived from Nostoc sp. FA1 to enhance mechanical stability and gastrointestinal resilience. TiO₂ nanoparticles were produced via a green biosynthetic route and integrated (0.5% w/v) into alginate–pectin matrices encapsulating Lactobacillus rhamnosus using extrusion. Structural and physicochemical analyses (FESEM, FTIR, XRD) confirmed that nanoparticle incorporation induced a 63.3% reduction in microstructural domain size (from 154.00 to 56.53 nm) and doubled the matrix crystallinity index (from 16.3% to 33.89%), resulting in a compact, low-porosity nanocomposite. Among tested formulations, the optimized system (2% alginate, 1.5% pectin, 0.5% TiO₂ NPs) significantly improved encapsulation efficiency and maintained probiotic viability above the therapeutic threshold (≥10⁶ CFU/g) after 120 min exposure to simulated gastric and intestinal fluids (p < 0.05). The optimized formulation reduced the decline in viability by 5.45-fold in the intestinal environment compared to free cells, markedly outperforming alginate-only capsules. This synergistic enhancement is attributed to the nanoscale void-filling effect and Ti–O–COO⁻ coordination interactions that reinforced the hydrogel network. This strategy offers a promising approach for improving the stability of probiotic-enriched foods, with potential implications for gut microbiota modulation and health-oriented nutraceutical development.
No takes yet. Share an insight, caveat, or question.
Golshadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: